patients attending the out-patient department of a tertiary level hospital. 2 A population based study showed the prevalence of IBS was 20.6% in male and 27.7% in female in a rural community of Bangladesh. 3 Despite much research, the pathophysiology of IBS remains poorly understood. 4 So, it is very difficult to treat patients with IBS. There is no standard treatment for IBS. Alleviating symptoms is one of the primary challenging goals of caring for IBS patients. Various pharmacological agents are available for treating IBS. The commonly used drugs are bulking agents, anti-diarrheal agents, anti-spasmodics and anti-depressant drugs. Very few drugs have proven to be of value in the management of IBS. A considerable placebo effect and methodological problem in recording efficacy make drug evaluation difficult. 5 In a review, Klein concluded that there is no therapeutic trial that ever demonstrated the efficacy of any drug in the treatment of IBS. 6 Because IBS symptoms can be elicited or exacerbated by diet and stress, and this suggests that patient education regarding the illness may be beneficial to the patients in managing their symptoms and thus may be beneficial to the society by improving self-management and decreasing health care utilization. 7 This has shown to be true for other chronic diseases such as asthma and heart disease. 8 However, little is known about the role of education in IBS. Therefore, the aim and objective of the present study was to study the effects of outpatient education on the short and long term outcomes of IBS patients in relation to change of symptom and quality of life.
Materials and Method
This is a prospective randomized controlled comparative study. The patients with abdominal pain/discomfort with altered bowel habit and visited the out-patient department of Gastroenterology Unit, Bangabandhu Sheikh Mujib Medical University (BSMMU) were invited to participate in the present study.
The inclusion criteria included the persons diagnosed as having IBS on the basis of Rome II criteria, must not having any red flag signs, age from 15 to 60 years and having minimum primary education level and who could fill up the questionnaire.
The inclusion criteria included the conditions that may affect the ability of the patient to fill up the questionnaire e.g. dementia, mental retardation, psychosis, blindness, etc; pregnant patients and women who breast feed their child and patients with concomitant severe illness like severe asthma, heart failure, renal disease or chronic liver disease were excluded because of the potential of these to affect symptomatology.
The patients who fulfilled the above criteria and had normal physical examination were considered to undergo screening investigations (Hb%, TC, DC, ESR, blood glucose, serum TSH, stool for R/M/E and short colonoscopy or double contrast barium enema) to exclude organic disease.
Study design
In this study, a total of 80 patients were included. IBS may be diarrhea predominant or constipation predominant. In order to administer the same pharmacological treatment only diarrhea predominant patients without any organic disease were recruited for the present study. Operationally, the diarrhea was defined as the patient's self-described passage of loose, soft stool and more than 3 motions/day. The patients randomly allocated to a group consisting of 40 patients (male 30, female 10) who were given only pharmacological management with Mebeverine Hydrochloride 135 mg thrice daily half an hour before meal and Amitryptyline 10 mg at night for 6 months, and the other 40 patients (male 29 and female 11) were given education by a structured and planned educational class for 1 hr in addition to the same pharmacological treatment. The emphasis of the class was to provide general education about IBS and healthy lifestyle modifications in the areas of diet, stress management and exercise, as well as appropriate use of medications.
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Results
Age range of the patients was 16 to 60 years. The mean age (SD) of education group was 28.7 (9.8) years whereas the mean age (SD) of without education group was 27.9 (5.6) years. There was no significant difference between the patient groups for any key demographic features. Total of nine patients dropped out from this study, three from the education group and six from the without education group.
There was no significant difference in severity of symptoms between drug treatment group (score 119.0) and education plus drug treatment group (score 119.6) at the baseline. Seventy one patients completed the trial. At baseline, 37 patients of the education group had pain score varying from 5-10 points. Even after one week from the start, the pain score was similar. In subsequent weeks, there was variation in improvement of abdominal pain score. At the end of four weeks 10 (27%) patients had marked improvement in abdominal pain and were varying from 0-4 points but the remainder 27 (83%) patients had no change in the abdominal pain. In the group without education, the scenario of experiencing pain was similar to that of education group as all 34 patients had pain score range between 5-10 points. However, at the end of four weeks, 7 (20%) had pain score in the range of 0-4 and the rest of the 27 (80%) patients remained as before. The difference of improvement between the education group and without education group was not statistically significant, though the subsidence of pain in both groups before and after treatment and/or education was statistically significant (p < 0.01).
On the other hand, regarding the bowel movement at the end of first week, all the patients of both the study groups had stool frequency of more than 3 times/day more than 50% of time at baseline. In the education group at the end of first week of treatment, 5 (13%) patients had less frequent motions i.e. more than 3 times/day, whereas 4 (12%) patients of without education group At the end of the class, the patients were provided with a leaflet containing the sum and substance of the class in Bengali so that patients can read the information again, understand it thoroughly and apply the rules and get improved. For stress management, all the 40 patients of education group were sent to the psychiatry department of BSMMU to attend the relaxation therapy.
Recruited patients were literate and were willing to come for weekly follow-up for first 1 month and the last follow-up after 6 months. Informed consent was taken. All patients were symptomatic at the time of inclusion period.
Assessment of improvement
In both groups, changes of symptoms and quality of life of the patients were assessed by using a valid IBS related quality of life (IBS-QOL) instrument.
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Symptom scoring of IBS included four major symptoms: abdominal pain, stool frequency, stool form and flatulence. Symptom score was applied before starting treatment at baseline and weekly for four weeks. A doctor on the basis of weekly interview did this scoring. A Bengali version QOL instrument was used which was previously used by the department of Gastroenterology, BSMMU. Bengali version IBS-QOL was given to each patient before the start of treatment, 1 month after treatment and after 6 months i.e. at the end of study pried. Patients themselves scored on IBS-QOL instrument. Improvement was assessed by changes of symptoms in symptoms scoring system and changes of score in IBS-QOL instrument.
Data processing and analysis
The chi-squared test was used to examine the difference between groups in case of symptom analysis. The difference between the two groups was examined by unpaired t-test and paired t-test in the same group before and after treatment to see the change in quality of life. highly significant (p < 0.001), but the difference in improvement between the two groups both at 1 month and 6 month was not statistically significant.
Discussion
IBS is the most common functional disorder of the alimentary tract in which bowel habits are altered in association with abdominal pain or discomfort, has a prevalence of 12% among adults in the United States and similar prevalence worldwide. 13 As the pathophysiology of IBS in not clearly understood, it is difficult to treat. But effective management may lessen the symptoms of IBS and may lead to improvement in QOL. Several groups of drugs have been used in the treatment of IBS like bulking agents, antidiarrheal, anti-spasmodics, anti-depressants, etc. 6 As IBS symptoms can be elucidated or exacerbated by diet or stress, patient education may be beneficial in managing their symptoms. 7 However, a little is known about its role in management of IBS. 10 The degree to which patient education in the areas of diet, exercise and stress management can improve symptoms of IBS is unknown. 14 Several studies have shown that education is effective in relieving symptoms and improving well-being in IBS patients. 15, 16 On the other hand, there are some other studies which failed to show significant benefit from educational class. 10, 16 There is no study to see the effects of education on IBS patients in Bangladesh. This study was conducted to observe the effect of education on IBS patients. Seventy one (57 male and 14 female) patients were included in this study (37 patients in group with education and 34 in group without education). Although the prevalence of IBS is higher in females, in this study female patients are less in number as they are reluctant to attend hospital and some also denied being included in the trial.
In this study, abdominal pain improved after one month of treatment in 27% of the group with education and 20% of the without education group. In a study by Colwell and others showed that pain decreased significantly at one month after education, in Mediscope 2015;2(2):22-27 25 achieved this improvement. At the end of 4 weeks treatment, 13 (35 % and 38%, respectively) patients in each group had less frequent motions. The improvement of stool frequency was significant in both the groups before and after treatment (p < 0.001), but the difference of improvement between the two groups was not significant.
Regarding the consistency of stool, in the group with education, 2 (5%) patients had less frequent (i.e. up to 25 % of baseline frequency) soft stool but none of the group without education at the end of one week treatment. There was variation in improvement in subsequent weeks. At the end of four weeks 15 (40%) patients in the group with education and 13 (38%) patients in the group without education group had marked improvement in stool consistency. The remaining 22 (60%) and 21 (62%), respectively were unchanged. The difference in improvement in both groups, before and after treatment was highly significant (p < 0.001), but the difference between the groups was not significant.
Among the 37 patients in the group with education, 22 (60%) had frequent flatulence and the remaining 15 (40%) had less frequent flatulence. There was variation in improvement in subsequent weeks of treatment. At the end of four weeks, 19 (51%) had less frequent and the rest 18 (49%) had frequent flatulence. Similarly in the group without education, 12 (36%) and 22 (64%) patients had less frequent and frequent flatulence, receptively before treatment. At the end of four weeks, this figure was 13 (38%) and 21 (62%), respectively. The improvement of flatulence was not significant in either group and between groups.
Regarding quality of life score, in the group with education, the mean score before treatment was 119.5 and in the group without education group it was 118.6. One month after treatment the mean score was 83.5 and 84.6, respectively. The improvement in QOL score at 1 month and 6 months after treatment in the both study groups was which the pain score came down from 3 (baseline) to 2.4 (after 1 month) on a scale 0-4. 14 In that study at baseline and at 1 month, there were significant associations between exercise and pain, more exercise was associated with less pain. On the contrary, in another study the pain severity scores decreased both for class attendees and non attendees; therefore, class attendance did not predict pain improvement by univariate and multivariate linear regression. 10 In this study, only diarrhea predominant patients were included. All the patients had stool frequency >3 times/day and soft stool. At the end of one month of treatment improvement of diarrhea was 35% in group with education and 38% in the without education group. Stool consistency improvement was 40% and 38%, respectively. Improvement occurred in both groups but difference was not statistically significant between the two groups. In one study with a 3 hr educational class, there was a 57% improvement in diarrhea at 1 month after treatment than baseline. This improvement was 71% at 6 months after the onset of treatment.
In our study, 60% patients in the group with education and 64% patients in the group without education had troublesome flatulence. After 4 weeks of treatment, the number of patients with flatus came down to some extent (49%) in the group with education but the number also went down in the group without education (62%). This improvement was not statistically significant. In a study in the United States, 77% of the patients had bloating at baseline but at the end of 1 month of treatment only 46% had bloating. 14 This study also showed a significant number of patients reporting no bloating of distension at 6 months. In these patients, nausea was also less at 1 month and 6 months and heart burn was less at 1 month. In anther study delivering IBS class consisting of 5 weekly 2 hr sessions of education on IBS on a biological mind body disease model emphasizing self efficacy (diet, medication, coping style) and practical instructions in simple relaxation techniques, the outcome measures at baseline and at 3 months showed an improvement in global severity of symptoms. 18 IBS-QOL instrument was used as a parameter of improvement in this trial. The results showed that significant improvement occurred in both the groups of patients at 1 month and 6 months in respect to their baseline IBS-QOL score. But the improvement was not significantly higher in the group with education in comparison to the group without education.
Conclusion
This study was conducted to observe the effect of education on IBS patients. The IBS-QOL instrument was used as a parameter of improvement in this trial. It showed that significant improvement occurred at 1 month and 6 months in respect to their baseline IBS-QOL score in both the groups of patients with and without educational class before the start of the study. But the improvement was not significantly higher in the group with education in comparison to the group without education. Therefore, it can be concluded that the educational class had no extra impact on drug treatment protocol for IBS used in the present study.
